|
|||||
|
|
Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach |
|
| Authors: | Rune V Overgaard PhD Søren Ø Lindberg MD Desirée Thielke MD |
| Institution: | 1. Department of Quantitative Clinical Pharmacology, Novo Nordisk A/S, Søborg, Denmark;2. Department of Medical and Science, Novo Nordisk A/S, Søborg, Denmark;3. Department of Global Medical Affairs, Novo Nordisk A/S, Søborg, Denmark |
| Abstract: | |
| Keywords: | antidiabetic drug GLP-1 GLP-1 analogue population study type 2 diabetes |